A study of the non-invasive evaluation of non-alcoholic fatty liver disease and liver fibrosis in patients with type 2 diabetes mellitus using Fibrosca
Not Applicable
Not yet recruiting
- Conditions
- Type 2 diabetes mellitusOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonLiver fibrosisMetabolic and Endocrine - Diabetes
- Registration Number
- ACTRN12609000221257
- Lead Sponsor
- The Alfred Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not yet recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Type 2 diabetes
Exclusion Criteria
Body Mass Index(BMI)>35
Bleeding disorder
Creatinine>200
International Normalised Ratio(INR)>1.5
Platelets<75
Anti-platelet agent use
Major medical co-morbidities
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method